Small Business: Endocrinology and Metabolism – EMS (10)
This special emphasis panel reviews small business applications in areas concerned with endocrine regulation, metabolic syndrome, diabetes and obesity. Included are studies addressing metabolic, molecular and neuroendocrine basis of energy expenditure and weight management, pathogenesis of obesity and diabetes and their management utilizing new and improved therapeutic strategies, bioengineering approaches in monitoring metabolic changes, and biomarkers. Applications may include clinical trials and studies in mammalian and non-mammalian systems.
Review Dates
Topics
- Energy balance, expenditure, thermogenesis, physical activity, exercise and bariatric surgery in the context of the pathogenesis or treatment of obesity and diabetes.
- Adipocyte functions, adiponectin secreatagogues, inflammation and anti-inflammatory agents. Stem cell delivery for adipose tissue repair.
- Devices development and testing in clinical management/ treatment of metabolic and endocrine disorders and diabetic complications.
- Diagnostic assay kits and automated assays for regulators of insulin synthesis.
- Neuroendocrinology and pharmacological interventions in other endocrine disorders. Such as acromegaly, thyroid and growth hormone disorders in adult, pediatric and neonatal population.
- Biosensor (e.g., glucose sensors-chemical, optical and electrochemical etc.) to effect continuous glucose monitoring for effective treatment of diabetes, drug delivery across cell and tissue systems.
- Differentiation, development, growth, and function of pancreatic islets, artificial pancreas. Beta cell viability and methods at optimization for use in islet transplantation and cell-based therapies.
